Omeros Corporation logo

Omeros Corporation

NASDAQ:OMER

Overview | Financials
Company Name Omeros Corporation
Symbol OMER
Currency USD
Price 8.9
Market Cap 515,753,220
Dividend Yield 0%
52-week-range 2.61 - 13.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Gregory A. Demopulos M.D.
Website https://www.omeros.com

An error occurred while fetching data.

About Omeros Corporation

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated

Related Stocks

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

0.744 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

1.38 USD

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.97 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

6 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

5 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

5.025 USD

Financials

Numbers are in millions USD

Numbers are in millions USD